1-phenyl-3,3-dimethyltriazene has been researched along with Macular Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hata, M; Kameda, T; Kojima, H; Kurimoto, Y; Mandai, M; Miyamoto, N | 1 |
1 other study(ies) available for 1-phenyl-3,3-dimethyltriazene and Macular Degeneration
Article | Year |
---|---|
[Five-year visual outcomes of typical age-related macular degeneration and/or polypoidal choroidal vasculopathy patients who received photodynamic therapy (PDT) as initial treatment in comparison with patients prior to the PDT era].
Topics: Age Factors; Aged; Aged, 80 and over; Choroid; Choroid Diseases; Female; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Treatment Outcome; Triazenes; Visual Acuity | 2012 |